SAM analyses were performed on the entire set of 20 breast cancers to identify potential differences in miRNA signatures between the following phenotypic groups: ErbB2-negative vs. ErbB2-positive, ER-positive vs. ER- negative, PR-positive vs. PR-negative, and mutated vs. wild type p53. Here, TP53 is linked to breast carcinoma.